Cannara Biotech Inc (LOVE.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 11-2024 | 08-2024 | 05-2024 | 02-2024 | 11-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,554 | 1,769 | 1,513 | 1,454 | 1,616 |
| Income taxes - deferred | 728 | N/A | N/A | N/A | N/A |
| Accounts receivable | 294 | -1,253 | 320 | -1,553 | 429 |
| Accounts payable and accrued liabilities | 1,046 | -156 | 1,846 | N/A | N/A |
| Other Working Capital | 332 | 97 | 2,313 | -883 | -4,508 |
| Other Operating Activity | 1,881 | 2,729 | -1,667 | 3,316 | 2,817 |
| Operating Cash Flow | $5,834 | $3,187 | $4,325 | $2,335 | $354 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,214 | -482 | -3,083 | -1,119 | -2,769 |
| Other Investing Activity | 40 | 45 | 2,139 | 44 | 36 |
| Investing Cash Flow | $-1,174 | $-436 | $-944 | $-1,075 | $-2,733 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 500 | 0 | -241 | N/A | 2,500 |
| Debt Issued | N/A | N/A | N/A | 1,000 | N/A |
| Debt Repayment | -599 | -572 | -571 | -560 | -521 |
| Common Stock Repurchased | 0 | 0 | 0 | N/A | -273 |
| Other Financing Activity | -921 | -1,022 | -236 | -1,208 | -958 |
| Financing Cash Flow | $-1,020 | $-1,594 | $-1,047 | $-768 | $747 |
| Beginning Cash Position | 6,620 | 5,464 | 3,131 | 2,639 | 4,271 |
| End Cash Position | 10,261 | 6,620 | 5,464 | 3,131 | 2,639 |
| Net Cash Flow | $3,641 | $1,156 | $2,334 | $491 | $-1,631 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,834 | 3,187 | 4,325 | 2,335 | 354 |
| Capital Expenditure | -1,217 | -493 | -3,083 | -1,119 | -2,774 |
| Free Cash Flow | 4,617 | 2,693 | 1,243 | 1,216 | -2,419 |